HRGN
Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology, Inc. insider trading
Insiders at Harvard Apparatus Regenerative Technology, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was He Junli (CEO · Director) buying $380K of HRGN, filed Sep 25, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $394.5K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 11, 2026
From SEC filings · last 30 days
Recent HRGN insider transactions
SEC Form 4 data, Q3 2024 to Q2 2026
HRGN insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, one insider traded HRGN on the open market: 6 purchases worth $57.2K and 0 sales. In the last four quarters alone: 4 purchases ($33.4K) and 0 sales, by one insider.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | — | — | |
| Q4 2025 | +$5.1K1 buy | — | |
| Q3 2025 | +$28.3K3 buys | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | +$6.6K1 buy | — | |
| Q3 2024 | +$17.2K1 buy | — |
- Largest purchase
- +$20.8K of HRGN by He Junli (CEO · Director) on Sep 02, 2025.
Open-market transactions through Jun 30, 2026most recent first
He Junli
CEO · Director
+$5.1K
Nov 25, 2025
3,000 sh · $1.70
He Junli
CEO · Director
+$594
Sep 30, 2025
300 sh · $1.98
He Junli
CEO · Director
+$20.8K
Sep 02, 2025
11,225 sh · $1.85
He Junli
CEO · Director
+$7K
Aug 21, 2025
4,050 sh · $1.72
He Junli
CEO · Director
+$6.6K
Dec 24, 2024
2,299 sh · $2.87
He Junli
CEO · Director
+$17.2K
Aug 27, 2024
5,101 sh · $3.37
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Nov 25, 2025 | He JunliCEO · Director | 3,000 | $1.70 | +$5.1K |
| Sep 30, 2025 | He JunliCEO · Director | 300 | $1.98 | +$594 |
| Sep 02, 2025 | He JunliCEO · Director | 11,225 | $1.85 | +$20.8K |
| Aug 21, 2025 | He JunliCEO · Director | 4,050 | $1.72 | +$7K |
| Dec 24, 2024 | He JunliCEO · Director | 2,299 | $2.87 | +$6.6K |
| Aug 27, 2024 | He JunliCEO · Director | 5,101 | $3.37 | +$17.2K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check HRGN — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Harvard Apparatus Regenerative Technology, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are HRGN insiders buying or selling?
- Between Sep 15, 2026 and Sep 11, 2026, 1 Harvard Apparatus Regenerative Technology, Inc. insider made 2 open-market purchases worth $394.5K and no sales, a net purchase of $394.5K.
- How much HRGN stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 1 Harvard Apparatus Regenerative Technology, Inc. insider made 6 open-market purchases worth $57.2K and no sales. In the four quarters to Jun 30, 2026: 4 purchases ($33.4K) and no sales. The largest purchase was He Junli buying $20.8K on Sep 02, 2025.
- What was the largest recent HRGN insider trade?
- He Junli (CEO · Director) bought $380K of HRGN stock on Sep 11, 2026 at about $1.05 a share.
- When did an insider last buy HRGN shares?
- The most recent open-market purchase on file is He Junli (CEO · Director) buying $14.5K on Sep 15, 2026. The largest purchase in the period was $380K by He Junli.
- Where does HRGN insider trading data come from?
- From the Form 4 filings Harvard Apparatus Regenerative Technology, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.